XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisitions (Tables)
9 Months Ended
Sep. 30, 2023
Business Acquisition [Line Items]  
Schedule of Consideration Transferred and the Respective Reporting Segment for Each Acquisition

In the nine months ended September 30, 2023, the Company acquired various other businesses which were accounted for under the acquisition method that complemented the Company’s existing product offerings. The following table reflects the consideration transferred and the respective reporting segment for the acquisitions (in millions):

 

Name of Acquisition

 

Date Acquired

 

Segment

 

Total
Consideration

 

 

Cash
Consideration

 

 

Goodwill

 

Acquifer Imaging GmbH and Deltabyte GmbH

 

January 4, 2023

 

BSI NANO

 

$

7.6

 

 

$

7.6

 

 

$

4.5

 

Pinpoint Testing LLC

 

March 28, 2023

 

BSI CALID

 

 

8.6

 

 

 

3.6

 

 

 

4.8

 

Fasmatech Science SA

 

March 3, 2023

 

BSI CALID

 

 

10.3

 

 

 

8.4

 

 

 

8.0

 

Interherence GmbH

 

July 3, 2023

 

BSI CALID

 

 

17.3

 

 

 

3.9

 

 

 

12.8

 

 

 

 

 

 

 

$

43.8

 

 

$

23.5

 

 

$

30.1

 

In the nine months ended September 30, 2023, the Company also made several strategic investments. The following table reflects the consideration transferred and the respective reporting segment for the investments (in millions):

Name

 

Financial
Statement
Classification

 

Date Acquired

 

Segment

 

Total
Consideration

 

 

Cash
Consideration

 

Tome Biosciences

 

Other long-term assets

 

July 26, 2023

 

Corporate

 

$

10.0

 

 

$

10.0

 

Other Investments

 

Other long-term assets

 

Various

 

Various

 

 

9.2

 

 

 

9.2

 

 

 

 

 

 

 

 

$

19.2

 

 

$

19.2

 

 

Biognosys Ag [Member]  
Business Acquisition [Line Items]  
Schedule of Components and Fair Value Allocation of the Consideration Transferred in Connection with Acquisitions

The components and fair value allocation of the consideration transferred in connection with the acquisition are as follows (in millions):

 

Consideration Transferred:

 

 

 

Cash paid

 

$

73.6

 

Cash acquired

 

 

(9.5

)

Holdback

 

 

0.2

 

Fair value of redeemable noncontrolling interest

 

 

2.5

 

Total consideration transferred

 

$

66.8

 

Allocation of Consideration Transferred:

 

 

 

Accounts receivable

 

$

3.6

 

Inventories

 

 

0.4

 

Other current assets

 

 

0.9

 

Property, plant and equipment

 

 

8.0

 

Other assets

 

 

4.3

 

Intangible assets:

 

 

 

Technology

 

 

10.2

 

Customer relationships

 

 

13.8

 

Trade name

 

 

2.7

 

Backlog

 

 

0.8

 

Goodwill

 

 

47.5

 

Liabilities assumed (a)

 

 

(25.4

)

Total consideration allocated

 

$

66.8

 

(a) This amount includes assumed liability for vested employee awards of $6.3 million on acquisition date and was settled in the post-closing period ended March 31, 2023.

Zontal Inc [Member]  
Business Acquisition [Line Items]  
Schedule of Components and Fair Value Allocation of the Consideration Transferred in Connection with Acquisitions

The components and fair value allocation of the consideration transferred in connection with the acquisition are as follows (in millions):

 

Consideration Transferred:

 

 

 

Cash paid

 

$

14.8

 

Cash acquired

 

 

(0.2

)

Fair value of contingent consideration

 

 

0.5

 

Fair value of hybrid liability

 

 

18.5

 

Total consideration transferred

 

$

33.6

 

Allocation of Consideration Transferred:

 

 

 

Accounts receivable

 

$

0.7

 

Other current assets

 

 

0.3

 

Other assets

 

 

1.2

 

Intangible assets:

 

 

 

Technology

 

 

5.8

 

Customer relationships

 

 

4.0

 

Trade name

 

 

1.1

 

Backlog

 

 

0.2

 

Goodwill

 

 

27.4

 

Liabilities assumed

 

 

(7.1

)

Total consideration allocated

 

$

33.6